General Motors
BP
Ford Motor Company
AstraZeneca
DaimlerChrysler
CNN
General Electric
US Senate
Credit Suisse First Boston
Volkswagen
Siemens
Philip Morris
Bloomberg
Verizon
Ericsson
AT&T
FIAT
Nestle
General Dynamics
UK Department of Trade & Industry
Sun Microsystems
AT&T
Hewlett Packard
AstraZeneca
AstraZeneca
ABN Amro
UBS Warburg
Merrill Lynch
New York Stock Exchange
HM Revenue & Customs
Credit Lyonnais
The Economist
General Motors
T-Mobile
France Telecom
Boeing
Lafarge
Safeway
People's Republic of China's
Ministry of Agriculture
Nordea
US State Department
Nestle
Lloyds
Tesco
Pfizer
Philips
Sybase
Pfizer
Sprint
3
New York Life Insurance
Canon USA
Novell
Ericsson
Siemens
EDS
US Department of Defense
Philip Morris International
Royal & SunAlliance
MOL
Novartis
Credit Lyonnais
AstraZeneca
Sun Microsystems
British American Tobacco
Norsk Hydro
AstraZeneca
Skanska
BAE Systems
Kodak
The Royal Mail Group
AstraZeneca
BP
Henkel
New York Life Insurance
Bank of Montreal
Danske Bank
BMW
Kronos Corporation
Fujitsu Technology Services
Zurich Financial Services
Halliburton
BBC
Ericsson
BBC
AT&T
Blue Cross/Blue Shield of Massachusetts
T-Mobile
Channel 4 Corporation
VHA
Burges Salmon
AstraZeneca
Macmillan Publishing
Motorola
Hewlett Packard
British Telecom
Philips
Ferrari
Deloitte & Touche
Nestle
PA Consulting
Philips
US Army
UK Department of Trade & Industry
EMC Corporation
US Department of Commerce
Vodafone Omnitel
Encana Corporation
Danske Bank
UK Department of Trade & Industry
Royal & SunAlliance
IEEE
Hewitt Associates LLC
Henkel
HEALTHvision
Paramount
Lexmark
US Department of Defense
3
JD Edwards
Ingersoll-Rand
Hewlett Packard
PricewaterhouseCoopers
Lloyds
Vodafone Omnitel
Nomura
US State Department
Reed Elsevier
US Department of Commerce
General Electric
Dow Chemical Company
Siemens Power Generation
Nestle
Siemens
Texas Instruments
Forrester Research
McData
US Department of Defense
Wall Street Journal
Lloyds
NASA
SCA
Reuters
ITN
IBM NICA
Nestle
Philips
Forbes.com
Nissan North America, Inc.
Toyota Motor
General Motors
The McGraw-Hill Companies
Fox Sports
AstraZeneca
Society of Petroleum Engineers
US Department of Energy
3
European Commission
Telecom Italia
Harrah's
AXA
Sybase
Napster
Oracle
Compuware
BBC
Olympus
ARM
Taylor & Francis
Britvic Softdrinks
The McGraw-Hill Companies
Federal Express
Nissan Motor
Milward Brown Precis
General Motors
Federal Government of Canada
UK Home Office
HM Revenue & Customs
Philips
3
ABN Amro
Harvard Business School
Britvic Softdrinks
MOL
Macmillan Publishing
3
Lloyds
Allianz Life Insurance Co
Swiss Army
Parliament of Singapore
Sun Microsystems
VMS
Singapore Police Force
Sony Music
3
GSA Advantage!
Kaiser Permanente
Swiss Army
Stanford Business School
Johns Hopkins
US State Department
General Motors
Wachovia
Standard Life Insurance
Raytheon
Commerzbank
Allstate Insurance
State of Washington
Napa Valley County
Texas Department of Transportation
US State Department
American HomePatient
TIBCO
Sharper Image
Ingersoll-Rand
Xerox
America Online
Lockheed Northrop Grumman
Dow Chemical Company
Draeger Medical
BP
BP
Sutter Health
Kenyan AIDS Clinic
3
Sun Microsystems
University of Washington
State of Minnesota
World Wildlife Fund
Autonomy Group Customers
 
Customer Services
Vertical Markets

Overview
Related Events
Related Case Studies
Related Resources
Related News

UK Department of Trade & Industry - iBio Video Case Study

Play the video
Find out more

Biotechnology is one of the UK's fastest growing industries, and the UK is second only to America as a leading force in this field. Obviously the public sector plays an enormous part in directing, regulating and funding this work. Endorsed by the Office of the E-Envoy, the UK's Department of Trade and Industry commissioned a cross-governmental project team tasked with creating an 'Information Biotechnology' portal to act as a single, reliable source of all UK biotechnology public information and research. This project secured funding from the Treasury's Invest-To-Save-Budget, a programme created to support innovative, leading edge initiatives that are firmly based on partnership working, and which in turn reduce organizational barriers, promoting joined up working, and streamline the move towards seamless service across government. But there was a significant challenge: at the same time as creating joined-up government, I.T. budgets were being cut and resource to undertake the project was growing scarce.

The DTI iBio team chose Autonomy to automatically aggregate all the disparate information and step around the barriers within government departments to draw together material without having to impinge on the technology within the individual departments. Autonomy's software analyzes patterns and identifies the concepts within information, whatever its format, rather than just searching for keywords. It gains an understanding of the context and meaning of information, allowing it to act upon information in highly complex ways. While keyword dependent technologies are manually intensive to maintain, and provide inaccurate results, Autonomy's unique ability to understand concepts delivers highly accurate, relevant results to users automatically and in real time.

http://www.i-bio.gov.uk/

There do not seem to be any upcoming events related to this page at the moment, please visit our seminar and webinar pages for more information.

There do not seem to be any case studies related to this page available yet, however please visit our publications site at http://publications.autonomy.com/ for more information.


Company
Technology
Functionality
Products
Solutions
Services
Customers
Partners
News & Events